Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Koenig Sheldon L.
Over the trailing 90 days, Koenig Sheldon L. (Director at Esperion Therapeutics, Inc.) sold $169K of stock in ESPR, per 5 SEC Form 4 transactions.
- Role
- Director
- Companies
- ESPR
- Window
- Trailing 90 days · 5 transactions · CIK 1766524
- Net activity
- −$169K ($0 bought · $169K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | 5 | — | $169K | −$169K |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-13 | ESPR | Sell | 753.0K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-13 | ESPR | Sell | 642.0K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-13 | ESPR | Sell | 2.1M | $0 | Disposition to the issuer of issuer equity securities |
| 2026-07-13 | ESPR | Sell | 647.5K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-06-17 | ESPR | Sell | 53.6K | $169K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Koenig's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.